Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma

Clinical trial NCT00044564 · COMPLETED

Trial details

NCT number: NCT00044564
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2001-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.